Skip to main content

Cano Health, Inc.

CANODelisted Feb 6, 2024
Industry
Services-Offices & Clinics of Doctors of Medicine
SEC CIK
0001800682

Cano Health, Inc. was delisted on Feb 6, 2024; its insiders filed their last Form 4 on Jul 2, 2024; 134 institutions reported holding it in 13F filings for Q3 2023, worth $24.0M in total; no superinvestor held it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Cano Health, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Cano Health, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Cano Health, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Nut Tree Capital Management, LP10% Owner, Other: See Remarks555,508IndirectJul 2, 20240
Nussbaum Jared R.10% Owner, Other: See Remarks555,508IndirectJul 2, 20240
Nut Tree Capital Management GP, LLC10% Owner, Other: See Remarks555,508IndirectJul 2, 20240
Trujillo Solomon DDirector0Jul 2, 20240
Muney AlanDirector0Jul 2, 20240
Rivera Kim MDirector0Jul 2, 20240
Morales Angel LDirector0Jul 2, 20240
Armstrong David JSee remarks0Jul 2, 20240
Camerlinck RobertChief Operating Officer0Jul 2, 20240
Kent Mark D.Interim CEO0IndirectJul 2, 20240
Gil EladioInterim CFO0Jul 2, 20240
ITC Rumba, LLC10% Owner516,007IndirectFeb 2, 20240
Cooperstone Elliot10% Owner516,007IndirectFeb 2, 20240
Hernandez MarlowOther: Former CEO / Director4,942,605Aug 25, 20230
Aguilar RichardChief Clinical Officer1,213,984Jun 30, 20230
Guichelaar JacquelineDirector248,500Jun 20, 20230
Koppy Brian DChief Financial Officer1,050,796Jun 2, 20230
Novell MarkChief Accounting Officer232,067Jun 2, 20230
Sternlicht Barry SDirector, 10% Owner12,854,233May 18, 20220
Gold LewisDirector362,902May 18, 20220
Jaws Sponsor LLC10% Owner0Jul 23, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 2, 2024 (view filing)6:56 AM ETJan 30-Feb 13 daysLateITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−22.7K$2.65−$60.2K−4.2%516.0K after3 lots
Jan 29, 2024 (view filing)8:07 PM ETJan 25-294 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−92.6K$2.71−$251.2K−14.7%538.7K after3 lots
Jan 24, 2024 (view filing)8:07 PM ETJan 22-242 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−233.8K$2.69−$629.2K−27.0%631.4K after3 lots
Jan 19, 2024 (view filing)4:47 PM ETJan 17-182 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−200.0K$2.11−$422.8K−18.8%865.2K after3 lots
Jan 12, 2024 (view filing)5:52 PM ETJan 10-122 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−74.2K$3.55−$263.0K−100.0%0 after3 lots
Jan 9, 2024 (view filing)9:32 PM ETJan 5-94 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−75.0K$3.81−$285.5K−50.3%74.2K after3 lots
Jan 4, 2024 (view filing)8:57 PM ETJan 2-42 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−131.8K$4.67−$615.6K−46.9%149.2K after4 lots
Dec 29, 2023 (view filing)5:31 PM ETDec 27-292 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−113.9K$5.88−$670.2K−28.8%281.0K after3 lots
Dec 26, 2023 (view filing)5:51 PM ETDec 21-265 daysITC Rumba, LLC and 1 other10% OwnerSSaleClass A Common Stock−137.7K$5.67−$781.1K−25.9%394.9K after4 lots
Aug 15, 2023 (view filing)Aug 114 daysCamerlinck RobertChief Operating OfficerSSaleClass A Common Stock−30.6K$0.77−$23.6K−0.1%27.0M after
Jun 30, 2023 (view filing)Jun 28-292 daysAguilar RichardChief Clinical OfficerSSaleClass A Common Stock−550.0K$1.29−$707.0K−31.2%1.21M after2 lots
Jun 13, 2023 (view filing)Jun 7-126 daysLateAguilar RichardChief Clinical OfficerSSaleClass A Common Stock−1.28M$1.36−$1.73M−51.2%1.21M after4 lots
Jun 7, 2023 (view filing)Jun 61 dayArmstrong David JSee remarksSSaleClass A Common Stock−3.16K$1.38−$4.36K−0.5%656.6K after
Apr 10, 2023 (view filing)9:40 PM ETApr 55 daysLateCamerlinck RobertChief Operating OfficerSSalePut option (obligation to sell)−20.0M–––0 afterDerivative
Apr 7, 2023 (view filing)Apr 52 daysKoppy Brian DChief Financial OfficerSSaleClass A Common Stock−23.6K$1.27−$30.0K−2.9%802.6K after
Apr 6, 2023 (view filing)Apr 51 dayHernandez MarlowCEOSSaleClass A Common Stock−17.1M–––13.5M afterDerivative2 lots
Apr 6, 2023 (view filing)Apr 51 dayHernandez MarlowCEOPPurchasePCIH Common Units/Class B Common Stock+8.54M–––8.54M afterDerivative
Apr 6, 2023 (view filing)Apr 51 dayAguilar RichardChief Clinical OfficerSSaleClass A Common Stock−9.98M–––5.89M afterDerivative2 lots
Apr 6, 2023 (view filing)Apr 51 dayAguilar RichardChief Clinical OfficerPPurchasePCIH Common Units/Class B Common Stock+4.99M–––4.99M afterDerivative
Mar 21, 2022 (view filing)Mar 174 daysGold LewisDirectorPPurchaseClass A Common Stock+300.0K$6.81+$2.04M+2,023.6%314.8K after
Dec 7, 2021 (view filing)Dec 61 dayHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+15.0K$8.00+$120.0K+0.5%2.89M after
Dec 7, 2021 (view filing)Dec 61 dayHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+15.0K$2.20+$33.0K–473.5K afterDerivative
Dec 6, 2021 (view filing)Dec 33 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+12.5K$8.75+$109.4K+0.4%2.88M after
Dec 6, 2021 (view filing)Dec 1-35 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+32.0K$2.45+$78.3K–458.5K afterDerivative2 lots
Dec 1, 2021 (view filing)Nov 301 dayHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+15.0K$2.39+$35.9K–426.5K afterDerivative
Nov 30, 2021 (view filing)Nov 1812 daysLateTrujillo Solomon DDirectorPPurchaseClass A Common Stock+97.0K$10.55+$1.02MNew position97.0K after
Nov 24, 2021 (view filing)Nov 222 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+8.00K$9.65+$77.2K+0.3%2.86M after
Nov 24, 2021 (view filing)Nov 22-232 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+30.0K$2.47+$74.0K–411.5K afterDerivative2 lots
Sep 14, 2021 (view filing)Aug 3015 daysLateAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+49.6K$10.75+$532.7K–675.9K afterDerivative2 lots
Sep 8, 2021 (view filing)Sep 44 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+140.0K$10.75+$1.50M–70.0K afterDerivative2 lots
Sep 2, 2021 (view filing)Aug 312 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+5.83K$11.99+$69.9K+0.4%1.52M after
Sep 2, 2021 (view filing)Aug 312 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+2.50K$11.99+$30.0K+3.8%67.6K after
Sep 2, 2021 (view filing)Aug 312 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+134.7K$3.77+$507.9K–47.0K afterDerivative2 lots
Sep 1, 2021 (view filing)Aug 302 daysAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+1.75K$11.93+$20.9K+1.4%125.2K after
Aug 31, 2021 (view filing)Aug 25-306 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+1.25M$10.82+$13.6M+488.2%1.51M after5 lots
Aug 31, 2021 (view filing)Aug 25-306 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+65.1K$11.90+$774.8KNew position65.1K after4 lots
Aug 31, 2021 (view filing)Aug 25-266 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+15.3K$3.73+$57.2K–287.2K afterDerivative2 lots
Aug 31, 2021 (view filing)Aug 25-266 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+6.57K$3.73+$24.5K–6.57K afterDerivative2 lots
Aug 31, 2021 (view filing)Aug 25-266 daysLateAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+123.4K$11.97+$1.48MNew position123.4K after2 lots
Aug 31, 2021 (view filing)Aug 25-306 daysLateAguilar RichardChief Clinical OfficerPPurchaseClass A Common Stock+1.35M$10.51+$14.2M–651.2K afterDerivative4 lots
Aug 24, 2021 (view filing)Aug 186 daysArmstrong David JSee remarksPPurchaseClass A Common Stock+15.0K$10.02+$150.3KNew position15.0K afterAmended
Aug 23, 2021 (view filing)Aug 18-205 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+46.9K$10.20+$478.4K+22.3%256.9K after3 lots
Aug 23, 2021 (view filing)Aug 18-205 daysLateHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+21.8K$2.81+$61.3K–271.8K afterDerivative3 lots
Aug 23, 2021 (view filing)Aug 16-177 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+210.0K$9.90+$2.08MNew position210.0K afterAmended2 lots
Aug 23, 2021 (view filing)Aug 16-177 daysHernandez MarlowCEO and PresidentPPurchaseClass A Common Stock+250.0K$2.68+$669.1K–250.0K afterAmendedDerivative2 lots